πŸ‡ΊπŸ‡Έ FDA
Patent

US 8957066

Histone deacetylase inhibitors

granted A61PA61P21/00A61P21/02

Quick answer

US patent 8957066 (Histone deacetylase inhibitors) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P21/00, A61P21/02, A61P21/04, A61P25/00